What is Ocular Therapeutix's total equity?

Ocular Therapeutix (OCUL) reported total equity of $581.57M in Q1 2026.

How has Ocular Therapeutix's total equity changed year-over-year?

Ocular Therapeutix's total equity increased by 118.7% year-over-year, from $265.93M to $581.57M.

What is the long-term trend for Ocular Therapeutix's total equity?

Over 5 years (2020 to 2025), Ocular Therapeutix's total equity has grown at a 53.8% compound annual growth rate (CAGR), from $76.1M to $654.31M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ocular Therapeutix OCUL Total Equity

Total Equity at other companies

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

Bausch + LombBLCO

$6.38B+0.3%

Tarsus Pharmaceuticals, Inc.TARS

$348.95M+1.9%

Kodiak Sciences IncKOD

$112.1M+3.0%

Ultragenyx PharmaceuticalRARE

-$236M-264%

PBH

Prestige Consumer HealthcarePBH

$1.89B+2.9%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's total equity?: Ocular Therapeutix (OCUL) reported total equity of $581.57M in Q1 2026.
How has Ocular Therapeutix's total equity changed year-over-year?: Ocular Therapeutix's total equity increased by 118.7% year-over-year, from $265.93M to $581.57M.
What is the long-term trend for Ocular Therapeutix's total equity?: Over 5 years (2020 to 2025), Ocular Therapeutix's total equity has grown at a 53.8% compound annual growth rate (CAGR), from $76.1M to $654.31M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.